Skip to main content
Outreach

Registration now open for the OC Foundation's Kids Without Cancer Race

  • It will take place on 22 September in Madrid and will involve the CiMUS Team, led by the researcher Pablo Aguiar.
  • The OC Against Cancer Foundation and the University of Santiago de Compostela have a collaboration agreement through which the foundation contributes to raising funds for the research project on nano radiopharmaceuticals against glioblastoma carried out by the university.

     

The race against childhood cancer opens a new chapter thanks to the Óscar Contigo Foundation, with the organisation of the second edition of the solidarity race Carrera Niños Sin Cáncer, on 22 September in Valdemorillo, Madrid, aimed at raising funds for research into this disease.

This year, thanks to the collaboration agreement with the OC Foundation, the CiMUS of the USC has an important role through its CiMUS Team, led by Pablo Aguiar, who will run to contribute to this cause and favour the financing of its nano-radiopharmaceutical research project against glioblastoma, directed by Aguiar himself and María José Alonso, and currently included in the USC's micro-patronage programme Sumo valor.

Anyone wishing to take part in the race can register at this link. You can also support this cause by making a donation to the CiMUS Team at the following link.

Glioblastoma, a lethal brain tumour

Glioblastoma is a type of brain tumour that can manifest itself at any age, but mostly occurs in adults between 45 and 70 years of age, and currently has no cure. The USC CiMUS study, led by María José Alonso and Pablo Aguiar, focuses on the use of nanotechnology for the treatment of this disease, delivering radiopharmaceuticals to the glioblastoma by means of an intravenous injection.

This study is part of the project ‘Early molecular nanoDIAGnostics of Brain tumors using ImmunePET (DIAGBI)’ of the call for R+D+i projects in strategic lines in public-private collaboration of the Ministry of Science and Innovation, but at the same time requires public participation to raise funds from private donations.

The University collects these contributions through the platform of the OC Against Cancer Foundation, which, among other events, also organises charity races to raise funds and fight against this disease.

‘The signing of this agreement is a step forward in the OC Foundation's objectives, as it allows us to broaden our scope of action and bring the necessary help to people suffering from a type of cancer for which there are very few lines of research,’ says Valérie Joly, president and founder of the OC Foundation. ‘Agreements like this encourage us to continue our efforts to raise awareness in society of the importance of investing in research into this disease.